Recurrence of Chronic Myeloid Leukemia during Pregnancy Subsequently Achieving Complete Medical Remission

The treatment of chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKIs) in reproductive-aged women poses major dilemmas concerning its associated teratogenicity as observed in many animal studies. Much controversy exists regarding continuation versus discontinuation of its use in preg...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhael, Sasha, Pascoe, Ashlee, Prezzato, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559931/
https://www.ncbi.nlm.nih.gov/pubmed/28840048
http://dx.doi.org/10.1155/2017/5651064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559931/
https://www.ncbi.nlm.nih.gov/pubmed/28840048
http://dx.doi.org/10.1155/2017/5651064

Ejemplares similares